|
|
ROI Metrics of eHealth: A Paradigm Shift or Business as Usual?Published by: Datamonitor Published: Apr. 29, 2002 - 35 Pages Table of ContentsDATAMONITOR HEALTHCARE ACTION POINTS Outline of the brief Four key recommendations regarding ROI Metrics for eHealth For all eHealth investments, key performance indicators should be established to secure management buy-in and help track implementation and benefits for future eHealth benchmarking There are myriad ways to approach the measurement of ROI in eHealth initiatives, each with its own weaknesses. Datamonitor recommends that the best models include both quantitative and qualitative performance indicators Return on process reengineering is as important as return on investment. Therefore, ROI metrics must be process-oriented, not just results-oriented The majority of technology vendors do not provide pharmaceutical companies with a cost/benefit analysis associated with the implementation of their IT solutions. Pharmaceutical companies should work with technology vendors to produce credible, appropriate and targeted indicators ROI METRICS FOR eHEALTH Introduction Methodology Establishment of metrics: how do pharmaceutical companies measure up? Demand for ROI metrics Gamblers and believers Case study: a believer testifies to the inherent benefits of a Web-enabled clinical trials query management system Skeptics and resistors Case study: a pharmaceutical company conducts extensive studies on Dot Com Advisor’s eDetailing offering Calculating the ROI of eHealth Operational cost comparisons Case study: CRF Box compares costs of wireless to telephone-based patient contact Net present value calculations Reduced time to market predictions Customer satisfaction surveys Sales data analysis Role of the vendor in designing ROI metrics Case study: PHT Technologies’ approach to ROI modeling THE FUTURE DECODED Recommendations for the design of future ROI metrics APPENDIX Additional information Table of figures Research methodology Datamonitor’s eHealthInsight Business Unit SPP writing team How to contact experts in your industry © Datamonitor 2002. All Rights Reserved. AbstractPharmaceutical company decision-makers are in disagreement about the merits of calculating the value of technology solutions. Some deem the demonstration of ROI unnecessary because Web-enabling processes is inevitable and desirable, while others view eHealth as any other initiative that requires metrics to demonstrate its value to the enterprise. This Brief analyzes the ROI conundrum and explains why eHealth performance indicators should be established. This analysis provides: * Case studies illustrating how pharmaceutical companies and vendors can tackle the problems associated with measuring ROI * Survey data revealing opinions of pharmaceutical eBusiness executives, helping companies benchmark their own approaches to ROI * Recommendations on how companies should design ROI models that will best serve them in the futureGet Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||